Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „irinotecan“
Suchtreffer
Begriffe & Kennungen
Darunavir Viatris (previously Darunavir Mylan) · 4.5 · Everolimus Concomitant use of everolimus or Irinotecan Irinotecan and boosted darunavir is not recommended. AN
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.5 · Everolimus Concomitant use of everolimus or Irinotecan Irinotecan and darunavir co- administered with low dose
Eintrag öffnenHMPC · hyperici-herba-0 / irinotecan · contraindicated
Eintrag öffnenHalaven · 4.8 · 9 1.23 mg/m2 on Days 1 and 8 and irinotecan 20 or 40 mg/m2 on Days 1 to 5 of a 21-day cycle, or 100 or 125 mg/
Eintrag öffnenHalaven · 4.8 · The safety profile of eribulin as monotherapy or in combination with irinotecan hydrochloride in this paediatr
Eintrag öffnenIrinotecan
Eintrag öffnenNexavar · 4.5 · Doxorubicin/Irinotecan
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.3 · History of severe hypersensitivity to irinotecan or to any of the excipients listed in section 6.1.
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.5 · Antineoplastic agents (including flucytosine as a prodrug for 5-fluorouracil) Adverse effects of irinotecan, s
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.5 · Strong CYP3A4 inducers Patients receiving concomitant non-liposomal irinotecan and CYP3A4 enzyme-inducing anti
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.5 · Strong CYP3A4 inhibitors and UGT1A1 inhibitors Patients receiving concomitant non-liposomal irinotecan and ket
Eintrag öffnenOnivyde pegylated liposomal (previously Onivyde) · 4.8 · In clinical studies of non-liposomal irinotecan administered on a weekly dosage schedule, patients with modest
Eintrag öffnenPrezista · 4.5 · Everolimus Concomitant use of everolimus or Irinotecan irinotecan and PREZISTA co-administered with low dose r
Eintrag öffnenPrezista · 4.5 · Everolimus Concomitant use of everolimus or Irinotecan irinotecan and boosted PREZISTA is not recommended.
Eintrag öffnenPrezista · 4.5 · Everolimus Concomitant use of everolimus or Irinotecan irinotecan and boosted PREZISTA is not recommended.
Eintrag öffnenPyrukynd · 4.5 · 6 (e.g. irinotecan [UGT1A1]; cyclophosphamide [CYP2B6]; valproic acid [CYP2C19]; paclitaxel [CYP2C8]; warfarin
Eintrag öffnenSymtuza · 4.5 · Everolimus Concomitant use of everolimus or Irinotecan irinotecan and Symtuza is not recommended.
Eintrag öffnenTeysuno · 4.3 · • Contraindications for cisplatin, oxaliplatin, irinotecan and bevacizumab; refer to the corresponding SmPCs.
Eintrag öffnenTeysuno · 4.3 · • Contraindications for cisplatin; oxaliplatin, irinotecan and bevacizumab refer to the corresponding SmPCs.
Eintrag öffnenTyverb · 4.5 · Co-administration of Tyverb with irinotecan (when administered as part of the FOLFIRI regimen) resulted in an
Eintrag öffnen